COMMUNIQUÉS West-GlobeNewswire

-
Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.
04/09/2025 -
MD Logic Health and Dr. Roxanne Carfora Launch Advanced Cholesterol Support: A Doctor-Created Formula for Heart and Metabolic Wellness
04/09/2025 -
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
04/09/2025 -
ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
04/09/2025 -
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/09/2025 -
Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders
04/09/2025 -
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
04/09/2025 -
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04/09/2025 -
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
04/09/2025 -
STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
04/09/2025 -
Silent Killer: HTLV 2026 Conference Launches Global Campaign to Fight HIV’s “Cousin” Virus Infecting Millions
04/09/2025 -
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
04/09/2025 -
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
04/09/2025 -
Indaptus Therapeutics Provides Clinical Update
04/09/2025 -
Praxis Precision Medicines to Participate in September Investor Conferences
04/09/2025 -
Inventiva to Participate in Upcoming September Investor Conferences
04/09/2025 -
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
04/09/2025 -
Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas
04/09/2025 -
What’s Really Going On With Federal Funding? SMI and Travis Taylor Lead iC³® Summit Panel Discussion to Deliver Clarity in a Volatile Policy Era
04/09/2025
Pages